Riverview Trust Company’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-255
Closed -$20.4K 635
2024
Q1
$20.4K Buy
+255
New +$22.7K 0.02% 468
2022
Q3
Sell
-121
Closed -$12K 749
2022
Q2
$12K Buy
+121
New +$14.5K 0.01% 620

Other funds holding CNMD

Riverview Trust Company's CNMD Position: Q2 2024 in Review

Riverview Trust Company sold out of CONMED (CNMD) in Q2 2024, closing a stake of 255 shares — an estimated $20.4K sold.

Riverview Trust Company first reported a position in CNMD in Q2 2022 and held it in 2 quarters. The position peaked at $20.4K in Q1 2024. 290 funds tracked by Wall St. Rank hold CNMD as of Q2 2024.

  • Riverview Trust Company reported no remaining CONMED position as of Q2 2024 after selling out during the quarter.
  • Riverview Trust Company sold 255 CONMED shares in Q2 2024, an estimated $20.4K.
  • Riverview Trust Company first reported a position in CONMED in Q2 2022 and held it in 2 quarters.
  • Riverview Trust Company's CONMED position peaked at $20.4K in Q1 2024.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q2 2024.

Based on Riverview Trust Company's 13F filing for Q2 2024, filed 16 Jul 2024.